To determine whether the pharmacological modulation of cAMP levels might nevertheless impact the cellular outcome induced by ATP at later time points, the four CRC cell lines were treated for 48 h with 250 μM ATP in the presence or absence of forskolin (FSK), a common activator of adenylyl cyclase (AC, Figure 6D). This evidence concerns the gene ASAH1 and colorectal carcinoma.